The global HIV antivirals market is set for a period of robust growth, with a new forecast predicting its value will climb ...

Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

The chronic lymphocytic leukemia therapeutics market is expected to grow at a compound annual growth rate of 7% from 2025 to ...

Although it sounds like an oxymoron, high-growth prospect dividend aristocrat stocks exist, although their industries may ...

The Inflation Reduction Act (IRA) authorized the federal government to force prescription drug manufacturers to "negotiate" drug prices for ...

Genmab reported strong Phase 3 trial results for epcoritamab in FL, secured FDA priority review, and raised its 2025 sales ...

Abbvie's stock rises 4.51% despite looming trade tensions and competitive pressures. Analysts from Morgan Stanley, Raymond ...

ROCKVILLE, Md., Aug. 7, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will initiate a pivotal Phase IIb/III clinical trial for investigational surabgene lomparvovec (sura-vec, ...

Scientists have found that lithium orotate — which is different from the kind of lithium typically used to treat mental health conditions — not only stopped the brain disease in mice but also reversed ...

Takeda Pharmaceutical Company saw its drug Entyvio (vedolizumab) approved in China by the National Medical Products ...

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...